coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Western Dales PCN, Westmorland and Furness (LAD) · Health Inequalities Profile

    PCN U59980 · NHS Lancashire and South Cumbria Integrated Care Board · 3 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    18,362

    Registered population

    50.7% aged 18–64

    31.8%

    Aged 65+

    ICB 20.0% · England 17.9%

    1.7%

    Ethnic minority (non-White)

    0.5% Asian

    0.0%

    In IMD quintile 1

    ICB 30.6% · England 21.0%

    0

    Core20 residents (est.)

    Resident basis; registered basis 0 · see page 3

    3,361

    Hypertension register

    +4.73% in 3 yrs · England +5.60%

    138

    SMI register

    6.3% of Westmorland and Furness (LAD)'s

    317

    COPD register

    Reviews +1.60% in 3 yrs

    Forecast to 2030

    3,782

    Hypertension patients, 2030

    +421 on today

    51.5%

    QRISK ≥20% on statins, 2030

    +0.81pp over 3 yrs

    7.0%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    49.8%
    Cardiovascular treatment lags behind strong BP monitoring.

    Lipid therapy for QRISK ≥ 20% is 49.8% (England 63.6%), and hypertension control is 67.2% (England 70.3%) despite 91.2% having recent BP readings.

    -13.9%
    Heart failure reviews and learning disability register fell.

    Over 2023 to 2025, heart failure reviews fell 13.9% to 68.2% (England +8.7%), and learning disability prevalence fell 9.1% to 0.4% (78 patients).

    76.6%
    Asthma reviews and cervical screening exceed England.

    Asthma annual reviews reach 76.6% (England 65.7%) after rising +11.2% over 2023 to 2025, while cervical screening (25-49 yrs) reaches 77.0% (England 66.8%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Patients aged 65+ comprise 31.8% of the list, well above England's 17.9%

    Western Dales PCN serves 18,362 registered patients across three practices ranging from 4,560 to 7,392 patients. Patients aged 65+ account for 31.8% (5,830), substantially higher than Westmorland and Furness (25.9%), NHS Lancashire and South Cumbria ICB (20.0%) and England (17.9%). Working-age adults (18–64) comprise 50.7% and children (0–17) 17.6%. Ethnic minority usual residents represent 1.7% (Asian 0.5%, Black 0.2%, Mixed 0.8%, Other 0.2%), while White residents represent 98.3%. Ethnicity figures reflect Census usual residents rather than GP registrations. Forecast population growth to 2030 is 2.0% (LAD 1.7%, ICB 1.7%, England 2.3%), though projection methods remain unverified.

    Age profile

    0–1717.6%
    18–6450.7%
    65+31.8%

    65+: ICB 20.0%, England 17.9%

    Ethnicity

    White98.3%
    Mixed0.8%
    Asian0.5%
    Other0.2%
    Black0.2%

    Older people · falls rows are Westmorland and Furness (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Westmorland and Furness LA)1,5912,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)85.7%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)58.1%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Westmorland and Furness LA)7361,0219552024/25
    Falls deaths, all ages, per 100,000 (Westmorland and Furness LA)10.518.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Average IMD decile is 7.1 with 0.0% of registered patients in Core20 areas

    Average IMD decile across Western Dales PCN is 7.1, compared with 6.0 in Westmorland and Furness (LAD), 5.0 in NHS Lancashire and South Cumbria Integrated Care Board and 5.5 in England. Across all three practices (Bentham Medical Practice, Lunesdale Surgery and Sedbergh Medical Practice), 0.0% of registered patients live in Core20 areas, against 9.2% in Westmorland and Furness (LAD), 30.6% in the ICB and 21.0% in England, with an estimated Core20 count of 0. This distribution does not exclude dispersed rural hardship, which may reflect household-level vulnerability rather than area.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Lunesdale0.0% · 0 patients
    Sedbergh Medical0.0% · 0 patients
    Bentham Medical0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    138

    SMI register

    0.74% recorded prevalence

    78

    Learning disability register

    0.42% recorded prevalence

    7

    Care homes, 160 beds

    In the PCN catchment

    Recorded learning disability prevalence is 0.4% (78 patients), below Westmorland and Furness (0.6%), the ICB (0.6%) and England (0.6%). Severe mental illness is 0.7% (138 patients; England 1.0%). Catchment capacity includes 7 care homes with 160 beds, while the borough recorded 14 people sleeping rough in 2025. Lower recorded prevalence than comparators could reflect demography or register practices, which clinical audit would test.

    Severe mental illness: physical health checks

    On the severe mental illness register (0.7%), blood pressure checks reached 85.8% (England 83.4%), but BMI recording was 76.1% (England 82.1%), dropping to 66.7% at Bentham Medical Practice. Metabolic monitoring shows practice-level variation.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    3,361

    Hypertension register

    +4.73%

    Register growth, 3 yrs

    Westmorland and Furness (LAD) +6.93% · England +5.60%

    +3.02pp

    BP control, under 80

    ≤140/90 · +0.24pp aged 80+

    +421

    More patients by 2030

    Forecast 3,782 (19.72%)

    Hypertension case-finding and control

    Hypertension recorded prevalence is 18.0% (3,361 patients), above England (15.2%) and close to Westmorland and Furness (LAD) (18.2%). While 91.2% of hypertension patients have a recent blood pressure reading (England 90.0%), blood pressure treated to target is 67.2% (England 70.3%, Westmorland and Furness (LAD) 71.7%). In patients aged under 80, control is 61.9% (England 67.8%), with Sedbergh Medical Practice at 52.1%, Bentham Medical Practice at 63.5%, and Lunesdale Surgery at 65.4%. Lower control despite high monitoring suggests treatment escalation protocols could be systematically prioritised.

    Lipids and statins

    Statin therapy for patients with QRISK ≥ 20% is 49.8%, below England (63.6%) and Westmorland and Furness (LAD) (59.6%). Primary prevention in diabetes reaches 61.0% (England 73.2%). Lower uptake than comparators supports systematic review of high-risk cohorts.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202646,602£1.20£1.64£1.86£55,922
    Cardiovascular (all), 202566,301£3.79£3.38£3.33£251,281

    The PCN prescribed 46,602 items of lipid-regulating drugs at £1.20 per item, below England (£1.86), Westmorland and Furness (LAD) (£1.68), and the ICB (£1.64), spending £30,757 less than at England's unit cost. Lower unit cost than comparators reflects formulary choices but does not measure prescribing efficiency.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +11.22%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −0.06%

    Asthma prevalence, PCN 3-yr % change

    Asthma prevalence is 8.4% (1,513 patients; England 6.6%, Westmorland and Furness (LAD) 7.9%). Asthma annual reviews reached 76.6% (England 65.7%), leaving 354 patients unreviewed. Second-hand smoke status recording for ages 6–19 was 82.3% (England 78.8%). COPD prevalence is 1.7% (317 patients; England 1.9%), where reviews reached 78.2% (England 76.4%). Prescribing of asthma management items for ages 5–19 was 1,348 rate per 1,000 (England 1,488 rate). Review delivery is strong, but proactive recall can address remaining unreviewed patients.

    Cancer register and children's immunisation

    Cancer recorded prevalence is 5.7% (1,061 patients; England 3.8%). In Q1 2025/26 childhood immunisations at age 5, MMR dose 1 reached 100.0% and dose 2 reached 90.9%. The 4-in-1 pre-school booster reached 84.8%, below the 95.0% target by 10.2 pp and below the ICB (85.2%). Bentham Medical Practice shows a 27.3 pp MMR dose difference. Immunisation drop-off between doses suggests targeted recall before school entry.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months93.5%

    England 91.0%

    6-in-1 complete primary course at 24 months89.7%

    England 92.2%

    MMR dose 1 at 24 months96.6%

    England 88.3%

    MMR dose 2 at age 590.9%

    England 82.8%

    4-in-1 pre-school booster at age 584.8%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    52.4%

    Lancashire and South Cumbria ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,010

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Lancashire and South Cumbria ICBEnglandNo usable stageStaged cancers
    Breast86.0%85.4%6%1,561
    Prostate42.4%53.2%11%1,404
    Lung31.1%33.8%15%1,374
    Bowel44.2%47.0%13%1,198
    Skin cancer86.1%87.8%21%519

    Across NHS Lancashire and South Cumbria ICB in 2022, 52.4% of cancers with a known stage (4,642 of 8,863) were diagnosed at stage 1 or 2 (England 55.3%), sitting 22.6 pp below the 75.0% national ambition by 2028, after falling 1.2 pp since 2013 (53.6%). Known-stage coverage was 74.6% (8,863 of 11,883). These system figures describe ICB pathways, not PCN performance. In Western Dales PCN, cancer prevalence is 5.7% (1,061 patients), rising +11.3% over 2023 to 2025 (England +9.0%). Breast screening coverage is 74.1% (England 69.9%; Westmorland and Furness LAD 76.3%), with Bentham Medical Practice at 68.3%.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026 (provisional), University Hospitals of Morecambe Bay NHS Foundation Trust achieved 72.4% on the 62-day cancer standard (12.6 pp below the 85.0% standard), compared with 73.2% at East Lancashire Hospitals NHS Trust, 75.0% at Lancashire Teaching Hospitals NHS Foundation Trust, 73.6% across NHS Lancashire and South Cumbria ICB, and 71.2% nationally. The trust met the 28-day faster diagnosis standard at 78.4% (standard 75.0%; England 79.3%). Diagnostic 6+ week waits were 10.4% overall (England 23.1%), but reached 13.8% for CT (England 9.9%). These figures reflect trust performance rather than PCN delivery.

    Pathways within standard (%)of Morecambe BayLancashireEast LancashireLancashire and South Cumbria ICBEngland
    28-day faster diagnosis (75%)78.3982.9081.5078.3979.32
    31-day treatment (96%)95.2289.4398.1193.6292.50
    62-day referral to treatment (85%)72.3575.0473.1673.6271.16
    Diagnostic waits over 6 weeks (%)of Morecambe BayLancashireEast LancashireEngland
    MRI4.042.410.4321.40
    CT13.7614.970.159.92
    Echocardiography10.5513.850.0028.48
    Colonoscopy0.600.000.9530.83
    Gastroscopy1.450.001.1629.02
    All 15 DM01 tests10.4426.653.2523.14
    Community services activityWestmorland and Furness residentsLancashire and South Cumbria ICB
    Care contacts53,485193,720
    Referrals6,47029,855
    Patients with a contact13,44565,335

    Community services (residents of Westmorland and Furness), Jun 2026 (provisional). In June 2026 (provisional), 249,980 community care activities were recorded for residents of Westmorland and Furness, contributing to 533,345 activities across NHS Lancashire and South Cumbria Integrated Care Board. Adults aged 65+ accounted for 67.9% of borough residents' contacts (36,330 of 53,485). These experimental activity figures reflect submitting providers across the local authority rather than individual PCN registered patients.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Overall QOF achievement exceeds national levels, but vaccination achievement varies by 44.0 pp across

    In 2025/26, overall QOF achievement across all three practices exceeded England (92.5%), reaching 93.7% at Bentham Medical Practice, 94.4% at Sedbergh Medical Practice, and 95.3% at Lunesdale Surgery. However, vaccination and immunisation domain achievement spanned a 44.0 pp range, from 45.2% at Bentham Medical Practice (below England's 55.2% by 10.0 pp) to 89.1% at Lunesdale Surgery.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Lunesdale Surgery1170.093.3%80.6%94.5%
    Sedbergh Medical1100.096.9%66.5%93.3%
    Bentham Medical1080.083.3%67.4%92.1%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNWestmorland and Furness (LAD)AssetPCNWestmorland and Furness (LAD)
    Care homes (catchment)7 (160 beds)n/aSchools (catchment)39n/a
    Children's centresno data12Places of worship79316
    Libraries314Food banks (VCS)12
    Day centres (VCS)12Children and young people (VCS)n/a3
    Carers support groups (VCS)n/a2Primary schools (LA maintained)1782
    Primary academiesn/a27Special schools14

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Cardiovascular treatment and lipid escalation

    Among 3,361 hypertension patients (18.0%), 91.2% have a recent reading, but control is 67.2% (England 70.3%) and under-80 control is 61.9% (England 67.8%). QRISK ≥ 20% lipid therapy is 49.8% (England 63.6%). Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 2

    Asthma annual review recall

    On the asthma register of 1,513 patients (8.4% prevalence; England 6.6%), annual review coverage is 76.6% (above England's 65.7%), leaving a modelled gap of 354 patients unreviewed. For discussion, the PCN could sustain standardised review templates and offer flexible or remote review slots to reach the remaining unreviewed patients. Low cost, quick to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 3

    Learning disability register validation

    Learning disability prevalence is 0.4% (78 of 18,362 patients) after falling 9.1% over 2023 to 2025, below the LAD and England (both 0.6%), giving a modelled gap of +23 to +30 patients. Low cost, quick to run.

    Evidence base: the register is the cohort for the annual health check and LeDeR learning; people with a learning disability die on average 20 years earlier and are a Core20PLUS5 PLUS group.

    Policy anchor: annual health checks for 75% of people aged 14+ on the register (Network Contract DES); Oliver McGowan mandatory training.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Learning disability register audit (p2)Learning disability: QOF prevalence75% annual health checks (Network Contract DES) · Oliver McGowanPCN
    SMI physical health check completion (p4)SMI register with a BMI recorded in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension medication titration review (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster recall outreach (p6)4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Targeted breast screening recall outreach (p7)Breast screening coverage: aged 53 to 70 years old—Practice
    Option 1 · Cardiovascular treatment and lipid escalation (p12)Hypertension register · Hypertension: QOF prevalence · Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN & Practice
    Option 2 · Asthma annual review recall (p12)Asthma register · Asthma: QOF prevalence · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 3 · Learning disability register validation (p12)Learning disability register · Learning disability: QOF prevalence · Registered population75% annual health checks (Network Contract DES) · Oliver McGowanPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15